Ownership and insider activity for Solventum Corporation (SOLV): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments.
Price
| Price | $88.03 |
| Market Cap | $15.2B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-01 | Hanson Bryan C | M-Exempt | 67,261 | |
| 2026-09-01 | Hanson Bryan C | F-InKind | 26,468 | $2.4M |
| 2026-09-01 | Hanson Bryan C | M-Exempt | 67,261 | |
| 2026-08-17 | Zieselman Neil Craig | A-Award | 6,911 | |
| 2026-08-10 | Zieselman Neil Craig | |||
| 2026-05-15 | ALBAN CARLOS | A-Award | 3,300 | |
| 2026-05-15 | COX CARRIE SMITH | A-Award | 4,848 | |
| 2026-05-15 | DeVore Susan D. | A-Award | 3,300 | |
| 2026-05-15 | Edwards Shirley Ann | A-Award | 3,300 | |
| 2026-05-15 | EISENBERG GLENN A | A-Award | 3,300 |
Balance Sheet (10y)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $91.0M | $61.0M | $194.0M | $762.0M | $878.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | $1.18B | $1.17B | $1.31B | $1.23B | $1.03B |
| Inventory | $813.0M | $873.0M | $857.0M | $965.0M | $1.07B |
| Total Current Assets | $2.19B | $2.23B | $2.52B | $3.25B | $3.86B |
| Property, Plant & Equipment | $1.31B | $1.32B | $1.46B | $1.62B | $1.33B |
| Goodwill | $6.67B | $6.43B | $6.54B | $6.38B | $5.70B |
| Intangible Assets | $3.66B | $3.25B | $2.90B | $2.54B | $2.59B |
| Total Assets | $14.07B | $13.59B | $13.94B | $14.46B | $14.29B |
| Accounts Payable | $320.0M | $348.0M | $477.0M | $618.0M | $687.0M |
| Short-term Debt | 0 | $27.0M | 0 | $200.0M | 0 |
| Total Current Liabilities | $1.41B | $1.31B | $1.73B | $2.70B | $3.14B |
| Long-term Debt | 0 | 0 | $8.30B | $7.81B | $5.04B |
| Total Liabilities | $2.02B | $1.85B | $2.28B | $11.50B | $9.24B |
| Retained Earnings | 0 | 0 | 0 | $242.0M | $1.80B |
| Total Equity | $12.06B | $11.74B | $11.67B | $2.96B | $5.05B |
| Total Debt | $112.0M | $95.0M | $8.30B | $8.01B | $5.04B |
| Net Debt | $21.0M | $34.0M | $8.11B | $7.25B | $4.16B |
| Working Capital | $783.0M | $920.0M | $791.0M | $546.0M | $723.0M |
Financial Health
| Debt / Equity | 1.10 |
| Current Ratio | 1.02 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.22 |
Profitability
| Return on Equity | 28.96% |
| Return on Invested Capital | 15.85% |
| Return on Assets | 10.07% |
| Gross Margin | 54.69% |
| Operating Margin | 24.99% |
| Net Margin | 17.26% |
Related companies: ALGN · DOCS · EHC · ELAN · ENSG · ICLR · QGEN
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of SOLV: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks